Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

(Former) Chief Scientific Off.

Executive Chairman

See Remarks

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and VXX-301, an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; VXX-401 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Merritt Island, Florida.

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascula...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-09-08	Premium	sold	Premium	Premium	Premium	-
2023-09-08	Premium	sold	Premium	Premium	Premium	-
2023-09-08	Premium	sold	Premium	Premium	Premium	-
2023-09-08	Premium	sold	Premium	Premium	Premium	-
2023-09-08	Premium	sold	Premium	Premium	Premium	-
2023-09-07	Premium	sold	Premium	Premium	Premium	-
2023-09-07	Premium	sold	Premium	Premium	Premium	-
2023-09-07	Premium	sold	Premium	Premium	Premium	-
2023-09-07	Premium	sold	Premium	Premium	Premium	-
2023-09-07	Premium	sold	Premium	Premium	Premium	-
2023-09-06	Premium	sold	Premium	Premium	Premium	-
2023-09-06	Premium	sold	Premium	Premium	Premium	-
2023-09-06	Premium	sold	Premium	Premium	Premium	-
2023-09-06	Premium	sold	Premium	Premium	Premium	-
2023-09-06	Premium	sold	Premium	Premium	Premium	-
2023-04-26	Premium	acquired	Premium	Premium	Premium	-
2023-01-23	Premium	sold	Premium	Premium	Premium	-
2023-01-23	Premium	sold	Premium	Premium	Premium	-
2022-12-02	Premium	sold	Premium	Premium	Premium	-
2022-12-02	Premium	sold	Premium	Premium	Premium	-
2022-12-01	Premium	sold	Premium	Premium	Premium	-
2022-12-01	Premium	sold	Premium	Premium	Premium	-
2022-09-06	Premium	sold	Premium	Premium	Premium	-
2022-09-06	Premium	sold	Premium	Premium	Premium	-
2022-09-06	Premium	sold	Premium	Premium	Premium	-

VAXX - Vaxxinity, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for VAXX